secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001636422-25-000023
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q4 revenue $79.6M (+6% YoY); raises 2025 Adjusted EBITDA target to $41M
--------------------------------------------------------------------------------

- Q4 revenue $79.6M (+6% YoY); full-year revenue $306.6M (+4% YoY).
- Net loss improved to $20.7M in Q4 ($30.3M prior year); full-year net loss $69.5M vs $118.1M.
- Technology segment Q4 revenue $52M (+10% YoY); full-year Tech revenue $195M.
- 2025 Adjusted EBITDA target raised to approximately $41M, up $2M from prior outlook.
- Director Anita Pramoda resigns effective March 1; Dr. Jill Hoggard Green joined Board Dec 1. Also promotions: Chief AI Officer and leadership team appointments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000023/0001636422-25-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000023/hcat-20250226.htm
  HTML page:      https://secwatch.observer/filing/0001636422-25-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer